Tag: metastatic castration-resistant prostate cancer

April 1, 2019 Off

ADXS-PSA in Combination with KEYTRUDA® Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer

Updated Results from Phase 1/2 Study to be Presented Today at the AACR Annual Meeting PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS),…

December 15, 2016 Off

By Dino Mustafić

Pfizer and Astellas Pharma have announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with…